BioTrinity 2023 will combine life science innovation and business

BioTrinity 2023

Life sciences membership organisation OBN (UK) will be holding in-person event BioTrinity 2023 in London on April 25-26.

The conference will feature two tracks: ‘Scientific’, showcasing innovation across eight core therapy areas, and ‘Life Sciences Business & Investment’.

Key features will include:

  • Showcase presentations from R&D companies at series A stage across oncology, neuroscience, microbiome, inflammatory diseases, rare diseases, infectious diseases, medtech and cell and gene therapy
  • A ‘Life Science Business & Investment’ track featuring panel discussions on regulatory, investment and exit trends, Green Science, and ESG
  • Three days of in-person and virtual one-to-one partnering meetings
  • Sponsor exhibitions
  • On and offsite networking opportunities including the BioTrinity Networking Party on 25 April

Stuart Rose, CEO of OBN, said: “We have a first-class speaker line-up and excellent delegate numbers which really shows that the appetite for in-person events is undiminished. We are looking forward to coming together to network, collaborate, share cutting-edge knowledge and to catalyse growth across the UK life sciences industry. We would like to thank our supporters and sponsors for making BioTrinity an ongoing success, and we look forward to welcoming everyone in April.”

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free